Literature DB >> 915001

Study of factors causing excess protoporphyrin accumulation in cultured skin fibroblasts from patients with protoporphyria.

J R Bloomer, D A Brenner, M J Mahoney.   

Abstract

The activity of heme synthetase, which catalyzes the chelation of ferrous iron to protoporphyrin to form heme, is deficient in sonicates of skin fibroblasts cultured from patients with protoporphyria. During culture in Eagle's medium supplemented with fetal calf serum, these cells do not accumulate protoporphyrin, however. This may be due to a minimal requirement for heme synthesis, since glycine is incorporated into heme at a low rate which is similar to that in normal fibroblasts. In addition, the activity of delta-aminolevulinic acid (ALA) synthetase, the first and rate-limiting enzyme of heme biosynthesis which catalyzes the formation of ALA from glycine, is normal in lysates of the fibroblasts. Cultured fibroblasts were therefore incubated with ALA in order to bypass the rate-limiting step of heme biosynthesis. In the presence of 25 muM iron, protoporphyrin was detected in protoporphyria cell lines when the concentration of ALA in the medium reached 50 muM, but not in normal lines. As the concentration of ALA was increased above 50 muM, all lines accumulated protoporphyrin. However, the amount was 2-3 times more in cultured fibroblasts from patients with protoporphyria, reflecting their deficiency of heme synthetase activity. When iron was not added to the medium, protoporphyrin accumulated to a similar degree in normal and protoporphyria fibroblasts; this was significantly more than that in the presence of iron. These studies indicate that excessive protoporphyrin accumulation in protoporphyria, which is due principally to deficient heme synthetase activity, may be modified by the rate of ALA formation in heme-producing tissues, and by the availability of iron.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 915001      PMCID: PMC372492          DOI: 10.1172/JCI108895

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Erythropoietic protoporphyria and lead intoxication: the molecular basis for difference in cutaneous photosensitivity. I. Different rates of disappearance of protoporphyrin from the erythrocytes, both in vivo and in vitro.

Authors:  S Piomelli; A A Lamola; M F Poh-Fitzpatrick; C Seaman; L C Harber
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

2.  Erythrocyte protoporphyrin in the detection of iron deficiency.

Authors:  G D McLaren; J T Carpenter; H V nino
Journal:  Clin Chem       Date:  1975-07       Impact factor: 8.327

3.  Decreased haem synthetase activity in blood cells of patients with erythropoietic protoporphyria.

Authors:  A F de Goeij; K Christianse; J van Steveninck
Journal:  Eur J Clin Invest       Date:  1975-09-12       Impact factor: 4.686

4.  Porphyrin synthesis and mitochondrial respiration in acute intermittent porphyria: studies using cultured human fibroblasts.

Authors:  H L Bonkowsky; D P Tschudy; E C Weinbach; P S Ebert; J M Doherty
Journal:  J Lab Clin Med       Date:  1975-01

5.  Isotopic studies of the erythropoietic and hepatic components of congenital porphyria and 'erythropoietic' protoporphyria.

Authors:  D C Nicholson; M L Cowger; J Kalivas; R P Thompson; C H Gray
Journal:  Clin Sci       Date:  1973-02       Impact factor: 6.124

6.  Erythropoietic defects in protoporphyria: a study of factors involved in labelling of porphyrins and bile pigments from ALA- 3 H and glycine- 14 C.

Authors:  S Schwartz; J A Johnson; B D Stephenson; A S Anderson; P R Edmondson; R M Fusaro
Journal:  J Lab Clin Med       Date:  1971-09

7.  The role of iron in the pathogenesis of porphyria cutanea tarda. II. Inhibition of uroporphyrinogen decarboxylase.

Authors:  J P Kushner; D P Steinmuller; G R Lee
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

8.  Inheritance in protoporphyria. Comparison of haem synthetase activity in skin fibroblasts with clinical features.

Authors:  J R Bloomer; H L Bonkowsky; P S Ebert; M J Mahoney
Journal:  Lancet       Date:  1976-07-31       Impact factor: 79.321

9.  Zinc protoporphyrin in the erythrocytes of patients with lead intoxication and iron deficiency anemia.

Authors:  A A Lamola; T Yamane
Journal:  Science       Date:  1974-12-06       Impact factor: 47.728

10.  Studies in porphyria. IV. Expression of the gene defect of acute intermittent porphyria in cultured human skin fibroblasts and amniotic cells: prenatal diagnosis of the porphyric trait.

Authors:  S Sassa; G Solish; R D Levere; A Kappas
Journal:  J Exp Med       Date:  1975-09-01       Impact factor: 14.307

View more
  16 in total

1.  The molecular defect of ferrochelatase in a patient with erythropoietic protoporphyria.

Authors:  Y Nakahashi; H Fujita; S Taketani; N Ishida; A Kappas; S Sassa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

2.  Mechanism governing heme synthesis reveals a GATA factor/heme circuit that controls differentiation.

Authors:  Nobuyuki Tanimura; Eli Miller; Kazuhiko Igarashi; David Yang; Judith N Burstyn; Colin N Dewey; Emery H Bresnick
Journal:  EMBO Rep       Date:  2015-12-23       Impact factor: 8.807

Review 3.  The ferrochelatase gene structure and molecular defects associated with erythropoietic protoporphyria.

Authors:  S Taketani; H Fujita
Journal:  J Bioenerg Biomembr       Date:  1995-04       Impact factor: 2.945

4.  Correction of the biochemical defect in porphobilinogen deaminase deficient cells by non-viral gene delivery.

Authors:  Annika Johansson; Christer Möller; Pauline Harper
Journal:  Mol Cell Biochem       Date:  2003-08       Impact factor: 3.396

Review 5.  Free radicals involvement in neurological porphyrias and lead poisoning.

Authors:  H P Monteiro; E J Bechara; D S Abdalla
Journal:  Mol Cell Biochem       Date:  1991-04-24       Impact factor: 3.396

6.  Characterization of deficient heme synthase activity in protoporphyria with cultured skin fibroblasts.

Authors:  J R Bloomer
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

7.  Bovine protoporphyria: documentation of autosomal recessive inheritance and comparison with the human disease through measurement of heme synthase activity.

Authors:  J R Bloomer; K O Morton; R J Reuter; G R Ruth
Journal:  Am J Hum Genet       Date:  1982-03       Impact factor: 11.025

8.  Uptake of protoporphyrin IX by isolated rat liver mitochondria.

Authors:  M E Koller; I Romslo
Journal:  Biochem J       Date:  1980-05-15       Impact factor: 3.857

9.  Protoporphyrin-induced cholestasis in the isolated in situ perfused rat liver.

Authors:  D L Avner; R G Lee; M M Berenson
Journal:  J Clin Invest       Date:  1981-02       Impact factor: 14.808

10.  Studies in porphyria: functional evidence for a partial deficiency of ferrochelatase activity in mitogen-stimulated lymphocytes from patients with erythropoietic protoporphyria.

Authors:  S Sassa; G L Zalar; M B Poh-Fitzpatrick; K E Anderson; A Kappas
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.